LISA LEE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner CHARLOTTE, NC NPI 1376093971

General Payments — all program years on this page

$1,396.47

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 58
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $363.10 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $363.1017

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $362.329
2022 $246.0712
2023 $424.9820
2024 $363.1017

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080651113 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $6.65 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080651133 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $15.64 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080651175 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $19.79 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080651307 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $8.92 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086997176 Novartis Pharmaceuticals Corporation $28.93 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086997178 Novartis Pharmaceuticals Corporation $28.93 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086997180 Novartis Pharmaceuticals Corporation $21.42 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100406396 Impulse Dynamics (USA) Inc. $26.92 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101372082 E.R. Squibb & Sons, L.L.C. $19.34 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117983570 Boehringer Ingelheim Pharmaceuticals, Inc. $18.88 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117983572 Boehringer Ingelheim Pharmaceuticals, Inc. $19.89 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117983574 Boehringer Ingelheim Pharmaceuticals, Inc. $24.57 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152391859 Kestra Medical Technology Services, Inc. $18.42 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154892085 Kiniksa Pharmaceuticals International, plc $28.21 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154892145 Kiniksa Pharmaceuticals International, plc $26.04 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154892165 Kiniksa Pharmaceuticals International, plc $24.18 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154892167 Kiniksa Pharmaceuticals International, plc $26.37 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.